文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

重症患者体外膜氧合串联连续性肾脏替代治疗通路的应用效果、通路安全性及感染相关因素分析

[Analysis of the application effect, access safety and infection-related factors of extracorporeal membrane oxygenation in series with continuous renal replacement therapy access in critically ill patients].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论回顾性倾向评分匹配显示,ECMO串联CRRT通路较独立操作可缩短CRRT启动与ICU停留时间、降低感染和出血事件发生率。

该研究回顾性纳入2020年12月至2024年12月淮安市第二人民医院ICU同时接受ECMO和CRRT治疗的200例危重症患者,按通路连接方式分为独立操作组72例与串联系统组128例,经1:1倾向评分匹配后每组各60例。匹配后串联系统组48小时ECMO流量、血肌酐、丙氨酸转氨酶显著降低,48小时LVEF显著升高,CRRT启动时间、CRRT导管留置时间、ICU停留时间显著缩短,置换液进出量显著增加。串联系统组感染发生率11.67%(7/60)vs 独立操作组36.67%(22/60)、出血事件发生率8.33%(5/60)vs 48.33%(29/60),均P<0.05。多因素Logistic回归显示导管留置时间(OR=1.277,95%CI 1.001-1.629,P=0.049)、PCT(OR=1.529,95%CI 1.222-1.914,P<0.001)、PLT(OR=0.953,95%CI 0.926-0.981,P=0.001)及通路连接方式(OR=0.289,95%CI 0.090-0.930,P=0.037)为感染的潜在影响因素。

要点

  • 匹配后串联系统组感染发生率11.67%(7/60)vs 独立操作组36.67%(22/60),出血事件8.33%(5/60)vs 48.33%(29/60),均P<0.05。
  • 串联系统组CRRT启动时间、CRRT导管留置时间及ICU停留时间较独立操作组显著缩短。
  • 串联系统组48小时ECMO流量、血肌酐、丙氨酸转氨酶较独立操作组显著降低,48小时LVEF显著升高。
  • 多因素Logistic回归示导管留置时间(OR=1.277,95%CI 1.001-1.629,P=0.049)与PCT(OR=1.529,95%CI 1.222-1.914,P<0.001)为感染潜在危险因素。
  • PLT(OR=0.953,95%CI 0.926-0.981,P=0.001)与串联系统连接方式(OR=0.289,95%CI 0.090-0.930,P=0.037)为感染的潜在保护因素。

适用人群与场景

  • 2020年12月至2024年12月在淮安市第二人民医院ICU同时接受ECMO和CRRT治疗的危重症患者200例,按ECMO与CRRT通路连接方式分为独立操作组72例和串联系统组128例。

研究设计与关键结果

  • 研究类型为回顾性研究,单中心,纳入200例,经1:1倾向评分匹配后成功匹配120例,独立操作组与串联系统组各60例,匹配后两组一般资料差异无统计学意义。
  • 与独立操作组相比,串联系统组48小时ECMO流量、血肌酐、丙氨酸转氨酶显著降低,48小时LVEF显著升高,CRRT启动时间、CRRT导管留置时间及ICU停留时间显著缩短,置换液进出量显著增加。
  • 串联系统组感染发生率11.67%(7/60)vs 独立操作组36.67%(22/60),出血事件发生率8.33%(5/60)vs 48.33%(29/60),均P<0.05;其余一般资料、治疗状态、临床结局指标及通路安全指标两组差异无统计学意义。
  • 120例中感染29例(24.17%),无感染91例(75.83%);感染组较非感染组导管留置时间显著延长、PCT显著升高,PLT及ECMO与CRRT通路串联连接比例显著降低。
  • 多因素Logistic回归显示导管留置时间(OR=1.277,95%CI 1.001-1.629,P=0.049)、PCT(OR=1.529,95%CI 1.222-1.914,P<0.001)、PLT(OR=0.953,95%CI 0.926-0.981,P=0.001)、通路连接方式(OR=0.289,95%CI 0.090-0.930,P=0.037)为感染的潜在影响因素。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ECMO串联CRRT通路可加速CRRT启动、避免局部出血、稳定患者心肝肾功能、降低潜在感染风险并改善预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the efficacy and access safety of extracorporeal membrane oxygenation (ECMO) in series with continuous renal replacement therapy (CRRT) access for critically ill patients using propensity score matching analysis, and to explore the potential influencing factors of infection.

METHODS: A total of 200 critically ill patients who received both ECMO and CRRT treatment in the intensive care unit (ICU) of Huai'an Second People's Hospital from December 2020 to December 2024 were retrospectively selected as the research subjects. They were divided into the independent operation group (72 cases) and the series system group (128 cases) according to the access connection mode of ECMO and CRRT. Propensity score matching analysis was used to perform 1 : 1 matching for patients of the two groups. The general data [age, gender, body mass index (BMI), clinical diagnosis, underlying disease, intubation method, intubation position, disease severity, ECMO support duration, catheter indwelling duration, oxygenation index (PaO2/FiO2) at 48 hours after ECMO initiation, serum creatinine (SCr), procalcitonin (PCT), hemoglobin (Hb), white blood cell count (WBC), platelet count (PLT)], treatment status [ECMO initiation duration, ECMO operation duration, ECMO flow, left ventricular ejection fraction (LVEF), CRRT initiation duration, CRRT catheter indwelling duration, inflow and outflow volume of replacement fluid], clinical outcome indicators (28-day survival rate, length of ICU stay, renal function recovery, fluid balance compliance rate), and access safety indicators (incidence of ECMO access thrombosis, incidence of infection, and incidence of bleeding events) of all the patients were collected. Subgroup analysis was conducted based on the occurrence of infection, and multivariate Logistic regression analysis was used to screen the potential risk factors for infection in critically ill patients receiving both ECMO and CRRT treatment.

RESULTS: Finally, a total of 120 patients were successfully matched, with 60 patients in both the independent operation group and the series system group. No statistically significant differences were observed in the general data between the two groups, indicating comparability. Compared with the independent operation group, the ECMO flow at 48 hours after ECMO initiation, SCr, and alanine transaminase (ALT) of the patients in the series system group were significantly decreased, while the LVEF at 48 hours after ECMO initiation was significantly increased, additionally, the CRRT initiation duration, CRRT catheter indwelling duration, and the length of ICU stay were significantly shortened, and the inflow and outflow volume of replacement fluid were significantly increased. The incidence of infection and bleeding events in the series system group was significantly lower than that in the independent operation group [infection incidence: 11.67% (7/60) vs. 36.67% (22/60), bleeding event incidence: 8.33% (5/60) vs. 48.33% (29/60), both P < 0.05]. No significant difference was found in the other general data, treatment status, clinical outcome indicators, or access safety indicators between the two groups. Among the 120 patients, 29 cases developed infection (accounting for 24.17%), and 91 cases had no infection (accounting for 75.83%). Compared with the non-infection group, the catheter indwelling duration was significantly prolonged and PCT was significantly increased in the infection group, while the PLT and the proportion of patients with ECMO and CRRT access connected via the series system were significantly decreased. Multivariate Logistic regression analysis showed that catheter indwelling duration [odds ratio (OR) = 1.277, 95% confidence interval (95%CI) was 1.001-1.629, P = 0.049], PCT (OR = 1.529, 95%CI was 1.222-1.914, P < 0.001], PLT (OR = 0.953, 95%CI was 0.926-0.981, P = 0.001), and access connection mode (OR = 0.289, 95%CI was 0.090-0.930, P = 0.037) were potential risk factors for infection in critically ill patients.

CONCLUSIONS: The ECMO-in-series CRRT access can accelerate the initiation of CRRT, avoid local bleeding, stabilize patients' cardiac, hepatic and renal functions, reduce potential infection risks, and improve the prognosis of patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhu X, Shi Y, Xie P, et al. [Analysis of the application effect, access safety and infection-related factors of extracorporeal membrane oxygenation in series with continuous renal replacement therapy access in critically ill patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41331892. doi:10.3760/cma.j.cn121430-20250324-00292

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。